BCTX
Briacell Therapeutics CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$29.22M
P/E Ratio
—
EPS
$-14.42
Beta
1.63
52W High
$45.60
52W Low
$3.60
50-Day MA
$4.12
200-Day MA
$7.61
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Briacell Therapeutics Corp
BriaCell Therapeutics Corp. The company is headquartered in West Vancouver, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-30.63M |
| Operating Margin | 0.00% |
| Return on Equity | -179.20% |
| Return on Assets | -89.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.26 |
| Price-to-Book | 0.91 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -1.38 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $7.25M |
| Float | $6.41M |
| % Insiders | 0.61% |
| % Institutions | 2.05% |
Historical Volatility
HV 10-Day
73.63%
HV 20-Day
63.40%
HV 30-Day
70.69%
HV 60-Day
65.05%
HV Rank
—
Volatility is currently expanding
Data last updated: 4/28/2026